Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients

Por Gharbaran, Rajendra, Goy, Andre, Tanaka, Takemi, Park, Jongwhan, Kim, Chris, Hasan, Nafis, Vemulapalli, Swathi, Sarojini, Sreeja, Tuluc, Madalina, Nalley, Kip, Bhattacharyya, Pritish, Pecora, Andrew, Suh, K Stephen
Publicado em 2013